Shilpa Medicare Ltd share price inched up 4.03% to Rs 648.4 after the company's net profit eased 6.41% to Rs 100.88 crore, while revenue from operations improved marginally 6.59% to Rs 465.78 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.82 lakh crore, rising 5.74%. It has improved by 0.41% over last one week and moving up by 11.45% in last one month while the market capitalization of Shilpa Medicare Ltd has marginally improved by 7.24% and 46.76% in the same period respectively. Profit before tax (PBT) of Shilpa Medicare Ltd stood at Rs 98.06 crore in Q2 FY26, expanding by 97.78% year-on-year, and tanking 18.58% quarter-on-quarter. EBITDA came in at Rs 133 crore, jumping 56.16% YoY and rising by 12.79% sequentially. Total expenses grew marginally by 4.83% to Rs 364.71 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 144.54 crore, advancing by 13.30% YoY, while employee benefits expense was at Rs 99.71 crore, surging 15.19% YoY. For the TTM ended FY26, revenue from operations rose 11.71% to Rs 1286.43 crore, while net profit saw a strong growth of 144.96% to Rs 78.29 crore, compared to previous TTM. EBITDA soared by 24044% to Rs 296.04 crore, and PBT soared 125.16% to Rs 122.33 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 132.18 crore in FY26, as against Rs 136.67 crore in FY25. Shilpa Medicare Ltd rallied 52.14% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.20% during the same period.
